Home › B-Cell Leukemia › Kentucky › Louisville
B-Cell Leukemia clinical trials in Louisville, KY
3 studies for B-Cell Leukemia are looking for participants at sites in and around Louisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Louisville
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RecruitingPhase 1
- Norton Cancer Institute, St. Matthews Campus, Louisville
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- Norton Cancer Institute, Louisville
B-Cell Leukemia trials in other cities
- Houston, TX7 studies
- Washington, DC5 studies
- Dallas, TX5 studies
- Columbus, OH4 studies
- Portland, OR4 studies
- Philadelphia, PA3 studies
- Spokane, WA3 studies
- Boston, MA3 studies
- New York City, NY3 studies
- Clifton, NJ3 studies
- San Diego, CA3 studies
- Charlotte, NC3 studies
Other studies in Louisville
- Non-Small Cell Lung Cancer22 studies
- Obesity17 studies
- Overweight15 studies
- Cancer (all types)14 studies
- Heart Failure13 studies
- Acute Myeloid Leukemia12 studies
- Ovarian Cancer12 studies
- Multiple Myeloma12 studies
- Lung Cancer11 studies
- Breast Cancer11 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Prostate Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.